Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Amortization of Deferred Charges (2019 - 2026)

Updated

Analysis

Elite Pharmaceuticals (ELTP) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Elite Pharmaceuticals 258.43 Mn 140.10 Mn 13.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 114,786.00
Mar 31, 2026 117,912.00
Dec 31, 2025 119,473.00
Sep 30, 2025 119,473.00
Jun 30, 2025 119,473.00
Mar 31, 2025 119,473.00
Dec 31, 2024 119,469.00
Sep 30, 2024 119,479.00
Jun 30, 2024 103,609.00
Mar 31, 2024 39,520.00
Dec 31, 2019 -48,051.00
Sep 30, 2019 -47,339.00
Jun 30, 2019 -46,635.00
API Access

Elite Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ELTP&period=max&api_key=YOUR_API_KEY